GRI insider transaction filings
GRI Bio, Inc. — 18 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-09-22. Screen GRI transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-09-22 | 4 | Chaturvedi Vipin — Chief Scientific Officer | Grant/award (A): 43,222 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | Hertz Walter Marc — Chief Executive Officer, Director | Grant/award (A): 103,067 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | Baker David Charles — Director | Grant/award (A): 23,605 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | SIMPSON CAMILLA V — Director | Grant/award (A): 23,605 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | Rongen Roelof — Director | Grant/award (A): 23,605 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | Szekeres David Leslie — Director | Grant/award (A): 39,897 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | Kelly Leanne — Chief Financial Officer | Grant/award (A): 43,222 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Hertz Walter Marc — Chief Executive Officer, Director | Grant/award (A): 26,688 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Baker David Charles — Director | Grant/award (A): 5,994 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Chaturvedi Vipin — Chief Scientific Officer | Grant/award (A): 11,854 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | SIMPSON CAMILLA V — Director | Grant/award (A): 5,994 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Rongen Roelof — Director | Grant/award (A): 5,994 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Szekeres David Leslie — Director | Grant/award (A): 10,276 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Kelly Leanne — Chief Financial Officer | Grant/award (A): 11,854 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Baker David Charles — Director | Grant/award (A): 4,527 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | SIMPSON CAMILLA V — Director | Grant/award (A): 4,527 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Rongen Roelof — Director | Grant/award (A): 4,527 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Szekeres David Leslie — Director | Grant/award (A): 7,545 (derivative) @ $0 | EDGAR |
Recent 8-K events — GRI Bio, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-06-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-21 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-16 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-01-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2026-01-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GRI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →